Name (Synonyms) | Correlation | |
---|---|---|
drug1724 | P2Et (Caesalpinia spinosa extract) Wiki | 1.00 |
drug1822 | Placebo Wiki | 0.06 |
Name (Synonyms) | Correlation | |
---|---|---|
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Safety and immunogenicity one-month study in healthy individuals administered once-daily pill of therapeutic vaccine made from heat-inactivated plasma from donors with COVID-19. Healthy, at least 20, volunteers will be monitored for signs of adverse events. Their PBMC will be collected at baseline and one month later to analyze which type of immune response vaccine has induced.
Description: Routine laboratory complete blood cell count at pre- and post-treatment periods by automated CBC counter Routine laboratory complete blood count Routine clinical laboratory CBC parameters at pre- and post-treatment periods
Measure: Effect on CBC as per CTCAE v4.0 Time: 15 DaysDescription: Routine clinical laboratory blood biochemistry parameters at pre- and post-treatment periods by automated biochemistry analyzer
Measure: Effect on biochemistry parameters as per CTCAE v4.0 Time: 15 DaysDescription: Clinical well-being assessed by CTCAE v4.0
Measure: Lack of adverse events as per CTCAE v4.0 Time: 15 days